Inventor · disambiguated record
Irving L. Weissman
Also filed as: WEISSMAN IRVING · WEISSMAN IRVING L · WEISSMAN SR IRVING L
146 granted patents·67 pending applications·3,924 citations·filing 1985–2025
99Inventor score
Files withUNIV LELAND STANFORD JUNIOR166SYSTEMIX INC7WEISSMAN IRVING L6STEMCELLS CALIFORNIA INC4FORTY SEVEN INC3
Top patents by PatentIndex Score
213 records- 0199US8361736B2Ex vivo methods for targeting or depleting acute myeloid leukemia cancer stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2010·Granted Jan 29, 2013·50 cites·8 claims
- 0298US11518806B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Dec 6, 2022·6 cites·34 claims
- 0398US11377495B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Jul 5, 2022·7 cites·7 claims
- 0498US11072655B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Jul 27, 2021·6 cites·3 claims
- 0598US9796781B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Oct 24, 2017·16 cites·2 claims
- 0698US9493575B2Methods for manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Nov 15, 2016·48 cites·7 claims
- 0798US9399682B2Methods for manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Jul 26, 2016·38 cites·7 claims
- 0898US9382320B2Humanized and chimeric monoclonal antibodies to CD47UNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Jul 5, 2016·36 cites·8 claims
- 0998US9017675B2Humanized and chimeric monoclonal antibodies to CD47UNIV LELAND STANFORD JUNIOR·Filed 2012·Granted Apr 28, 2015·66 cites·8 claims
- 1098US8709429B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Apr 29, 2014·30 cites·12 claims
- 1198US5750397AHuman hematopoietic stem cellSYSTEMIX INC·Filed 1995·Granted May 12, 1998·376 cites·7 claims
- 1298US5061620AHuman hematopoietic stem cellSYSTEMIX INC·Filed 1990·Granted Oct 29, 1991·691 cites·7 claims
- 1397US11136391B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Oct 5, 2021·9 cites·17 claims
- 1497US9765143B2Methods for manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Sep 19, 2017·17 cites·10 claims
- 1597US9624305B2Methods of manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Apr 18, 2017·17 cites·3 claims
- 1697US9611329B2Methods of manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Apr 4, 2017·19 cites·3 claims
- 1797US9605076B2Methods of manipulating phagocytosis mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Mar 28, 2017·19 cites·3 claims
- 1897US9562087B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Feb 7, 2017·45 cites·30 claims
- 1997US9546206B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Jan 17, 2017·33 cites·27 claims
- 2097US5716827AHuman hematopoietic stem cellSYSTEMIX INC·Filed 1995·Granted Feb 10, 1998·258 cites·2 claims
- 2196US11608377B2Enhanced depletion of targeted cells with CD47 blockade and an immune costimulatory agonistUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Mar 21, 2023·7 cites·15 claims
- 2296US11603404B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Mar 14, 2023·3 cites·36 claims
- 2396US11208481B2High affinity SIRP-alpha reagents and methods of usingUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Dec 28, 2021·7 cites·28 claims
- 2496US11141480B2Dosing parameters for CD47 targeting therapies to hematologic malignanciesUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Oct 12, 2021·9 cites·6 claims
- 2596US10781256B2Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodiesUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Sep 22, 2020·14 cites·14 claims
- 2696US10081680B2Anti-SIRP-alpha antibodies and bispecific macrophage enhancing antibodiesUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Sep 25, 2018·42 cites·15 claims
- 2796US9623079B2Methods for achieving therapeutically effective doses of anti-CD47 agents for treating cancerUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Apr 18, 2017·26 cites·12 claims
- 2896US9193955B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Nov 24, 2015·10 cites·4 claims
- 2996US8758750B2Synergistic anti-CD47 therapy for hematologic cancersWEISSMAN IRVING L·Filed 2010·Granted Jun 24, 2014·50 cites·8 claims
- 3096US8562997B2Methods of treating acute myeloid leukemia by blocking CD47JAISWAL SIDDHARTHA·Filed 2010·Granted Oct 22, 2013·93 cites·2 claims
- 3196US7514229B2Methods for diagnosing and evaluating treatment of blood disordersUNIV LELAND STANFORD JUNIOR·Filed 2006·Granted Apr 7, 2009·49 cites·8 claims
- 3296US5643741AIdentification and isolation of human hematopoietic stem cellsSYSTEMIX INC·Filed 1995·Granted Jul 1, 1997·210 cites·7 claims
- 3395US10723803B2CD47 targeted therapies for the treatment of infectious diseaseUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Jul 28, 2020·8 cites·13 claims
- 3495US10662242B2Markers of acute myeloid leukemia stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted May 26, 2020·6 cites·1 claims
- 3595US9944911B2High affinity Sirp-alpha reagents and methods of usingUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Apr 17, 2018·23 cites·15 claims
- 3695US6465247B1Mammalian myeloid progenitor cell subsetsUNIV LELAND STANFORD JUNIOR·Filed 2000·Granted Oct 15, 2002·110 cites·9 claims
- 3795US5914108AHuman hematopoietic stem cellSYSTEMIX INC·Filed 1995·Granted Jun 22, 1999·166 cites·4 claims
- 3894US10611842B2Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPα antibody therapyUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Apr 7, 2020·8 cites·15 claims
- 3994US10316094B2Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistanceUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Jun 11, 2019·9 cites·17 claims
- 4094US10301387B2Methods for achieving therapeutically effective doses of anti-CD47 agentsUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted May 28, 2019·11 cites·15 claims
- 4194US6465249B2Use of β-catenin in the expansion of stem and progenitor cellsUNIV LELAND STANFORD JUNIOR·Filed 2001·Granted Oct 15, 2002·64 cites·17 claims
- 4294US2025333502A1Methods for Manipulating Phagocytosis Mediated by CD47UNIV LELAND STANFORD JUNIOR·Filed 2024·Application pending·0 cites
- 4393US12030944B2Enhanced depletion of targeted cells with CD47 blockade and an immune costimulatory agonistUNIV LELAND STANFORD JUNIOR·Filed 2023·Granted Jul 9, 2024·1 cites·22 claims
- 4493US10800830B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Oct 13, 2020·6 cites·17 claims
- 4593US10406179B2Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signalingUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Sep 10, 2019·16 cites·15 claims
- 4693US7803783B2Use of WNT inhibitors to augment therapeutic index of chemotherapyUNIV LELAND STANFORD JUNIOR·Filed 2007·Granted Sep 28, 2010·22 cites·3 claims
- 4793US7641897B2Feeder layer and serum independent embryonic stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2005·Granted Jan 5, 2010·19 cites·3 claims
- 4893US6991939B2Optical array device and methods of use thereof for screening, analysis and manipulation of particlesUNIV TUFTS·Filed 2002·Granted Jan 31, 2006·92 cites·31 claims
- 4993US6761883B2Mammalian myeloid progenitor cell subsetsUNIV LELAND STANFORD JUNIOR·Filed 2001·Granted Jul 13, 2004·63 cites·6 claims
- 5092US12195532B2High affinity SIRP-alpha reagents and methods of usingUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Jan 14, 2025·1 cites·10 claims
Showing the top 50 of 213 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Irving L. Weissman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →